RATIONALE: The incidence of influenza-associated acute respiratory failure is unknown. OBJECTIVES: To estimate the population-based incidence of influenza-associated acute respiratory failure hospitalizations. METHODS: This is a cohort study from January 2003 through March 2009 using hospitalization databases for Arizona, California, and Washington from the Healthcare Cost and Utilization Project and influenza surveillance data for regions encompassing these states. Acute respiratory failure requiring mechanical ventilation was defined by International Classification of Diseases-9-CM code. We used negative-binomial regression modeling to estimate the incidence of influenza-associated events. MEASUREMENTS AND MAIN RESULTS: The incidence of influenza-associated acute respiratory failure was 2.7 per 100,000 person-years (95% confidence interval, 0.2-23.5), and during the influenza season, 3.8% of all respiratory failure hospitalizations were attributable to influenza. Compared with adults aged 18-49 years, the incidence rate ratio for influenza-associated acute respiratory failure was lower among children aged 1-4 (0.9) and 5-17 years (0.3); however, it was higher among adults aged 50-64 (4.8), 65-74 (10.4), 75-84 (19.9), and 85 years and older (33.7). Results were similar with more sensitive and specific outcome definitions and in a sensitivity analysis using only Arizona-specific outcome and surveillance data. CONCLUSIONS: Our data indicate that influenza was an important contributor to respiratory failure hospitalizations during 2003-2009. Clinicians should maintain a high index of suspicion for influenza among hospitalized patients with acute respiratory illness when influenza is circulating in a community. Influenza has a greater effect on respiratory failure in the elderly, for whom better prevention measures are needed.
RATIONALE: The incidence of influenza-associated acute respiratory failure is unknown. OBJECTIVES: To estimate the population-based incidence of influenza-associated acute respiratory failure hospitalizations. METHODS: This is a cohort study from January 2003 through March 2009 using hospitalization databases for Arizona, California, and Washington from the Healthcare Cost and Utilization Project and influenza surveillance data for regions encompassing these states. Acute respiratory failure requiring mechanical ventilation was defined by International Classification of Diseases-9-CM code. We used negative-binomial regression modeling to estimate the incidence of influenza-associated events. MEASUREMENTS AND MAIN RESULTS: The incidence of influenza-associated acute respiratory failure was 2.7 per 100,000 person-years (95% confidence interval, 0.2-23.5), and during the influenza season, 3.8% of all respiratory failure hospitalizations were attributable to influenza. Compared with adults aged 18-49 years, the incidence rate ratio for influenza-associated acute respiratory failure was lower among children aged 1-4 (0.9) and 5-17 years (0.3); however, it was higher among adults aged 50-64 (4.8), 65-74 (10.4), 75-84 (19.9), and 85 years and older (33.7). Results were similar with more sensitive and specific outcome definitions and in a sensitivity analysis using only Arizona-specific outcome and surveillance data. CONCLUSIONS: Our data indicate that influenza was an important contributor to respiratory failure hospitalizations during 2003-2009. Clinicians should maintain a high index of suspicion for influenza among hospitalized patients with acute respiratory illness when influenza is circulating in a community. Influenza has a greater effect on respiratory failure in the elderly, for whom better prevention measures are needed.
Authors: Jon M Florence; Agnieszka Krupa; Laela M Booshehri; Sandra A Davis; Michael A Matthay; Anna K Kurdowska Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-03-08 Impact factor: 5.464
Authors: Christopher A Czaja; Lisa Miller; Nisha Alden; Heidi L Wald; Charisse Nitura Cummings; Melissa A Rolfes; Evan J Anderson; Nancy M Bennett; Laurie M Billing; Shua J Chai; Seth Eckel; Robert Mansmann; Melissa McMahon; Maya L Monroe; Alison Muse; Ilene Risk; William Schaffner; Ann R Thomas; Kimberly Yousey-Hindes; Shikha Garg; Rachel K Herlihy Journal: Open Forum Infect Dis Date: 2019-07-01 Impact factor: 3.835
Authors: Justin R Ortiz; Kathleen M Neuzil; David K Shay; Tessa C Rue; Moni B Neradilek; Hong Zhou; Christopher W Seymour; Laura G Hooper; Po-Yung Cheng; Christopher H Goss; Colin R Cooke Journal: Crit Care Med Date: 2014-11 Impact factor: 7.598
Authors: G R Scott Budinger; Ronald A Kohanski; Weiniu Gan; Michael S Kobor; Luis A Amaral; Mary Armanios; Karl T Kelsey; Annie Pardo; Rubin Tuder; Fernando Macian; Navdeep Chandel; Douglas Vaughan; Mauricio Rojas; Ana L Mora; Elizabeth Kovacs; Steven R Duncan; Toren Finkel; Augustine Choi; Oliver Eickelberg; Danica Chen; Alvar Agusti; Moises Selman; William E Balch; Paula Busse; Anning Lin; Richard Morimoto; Jacob I Sznajder; Victor J Thannickal Journal: J Gerontol A Biol Sci Med Sci Date: 2017-10-12 Impact factor: 6.053
Authors: Victor J Thannickal; Mahadev Murthy; William E Balch; Navdeep S Chandel; Silke Meiners; Oliver Eickelberg; Moisés Selman; Annie Pardo; Eric S White; Bruce D Levy; Paula J Busse; Rubin M Tuder; Veena B Antony; Jacob I Sznajder; G R Scott Budinger Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405
Authors: Ranjani Somayaji; Christopher H Goss; Umer Khan; Moni Neradilek; Kathleen M Neuzil; Justin R Ortiz Journal: Clin Infect Dis Date: 2017-06-15 Impact factor: 9.079
Authors: Alexandra C McQuattie-Pimentel; Ziyou Ren; Nikita Joshi; Satoshi Watanabe; Thomas Stoeger; Monica Chi; Ziyan Lu; Lango Sichizya; Raul Piseaux Aillon; Ching-I Chen; Saul Soberanes; Zhangying Chen; Paul A Reyfman; James M Walter; Kishore R Anekalla; Jennifer M Davis; Kathryn A Helmin; Constance E Runyan; Hiam Abdala-Valencia; Kiwon Nam; Angelo Y Meliton; Deborah R Winter; Richard I Morimoto; Gökhan M Mutlu; Ankit Bharat; Harris Perlman; Cara J Gottardi; Karen M Ridge; Navdeep S Chandel; Jacob I Sznajder; William E Balch; Benjamin D Singer; Alexander V Misharin; G R Scott Budinger Journal: J Clin Invest Date: 2021-02-15 Impact factor: 14.808